Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting

ABSTRACT

Seminal vesicle protein 4 (SV-IV) is a highly flexible molecule that in aqueous solution behaves as a concentration-dependent self-associating system in which the degree of association (monomer ↔ dimer ↔ trimer equilibrium) seems to be related to its biological activities. This review reports the functional role of SV-IV in seminal clotting exerted through the modulation of inflammation, hemostasis, and sperm protection against the damage induced by immunological or reactive oxygen species during the long journey of spermatozoa in the female genital tract.

KEYWORDS

Seminal clotting - prostate transglutaminase - SV-IV protein - hemostatic factors

REFERENCES

• 1 Ostrowski M C, Kistler M K, Kistler W S. Purification and cell-free synthesis of a major protein from rat seminal vesicle secretion. A potential marker for androgen action.  J Biol Chem. 1979;  254 383-390
• 2 Mansson P E, Sugino A, Harris S E. Purification and cell-free synthesis of a major protein from rat seminal vesicle secretion. A potential marker for androgen action.  Nucleic Acids Res. 1981;  9 935-946
• 3 Pan Y C, Li S S. Structure of secretory protein IV from rat seminal vesicles.  Int J Pept Protein Res. 1982;  20 177-187
• 4 Dyson H J, Wright P E. Intrinsically unstructured proteins and their functions.  Nat Rev Mol Cell Biol. 2005;  6 196-207
• 5 Stiuso P, Metafora S, Facchiano A M et al.. The self-association of protein SV-IV and its possible functional implications.  Eur J Biochem. 1999;  266 1029-1035
• 6 Caporale C, Caruso C, Colonna G et al.. Structural properties of the protein SV-IV.  Eur J Biochem. 2004;  271 263-271
• 7 Metafora S, Peluso G, Persico P et al.. Immunosuppressive and anti-inflammatory properties of a major protein secreted from the epithelium of the rat seminal vesicles.  Biochem Pharmacol. 1989;  38 121-131
• 8 Camussi G, Tetta C, Bussolino F et al.. An anti-inflammatory protein secreted from the rat seminal vesicle epithelium inhibits the synthesis of platelet-activating factor and the release of arachidonic acid and prostacyclin.  Eur J Biochem. 1990;  192 481-485
• 9 Persico P, Mancuso F, Metafora S et al.. In vivo and in vitro inhibition of platelet aggregation by SV-IV, a major protein secreted from the rat seminal vesicle epithelium.  Biochem Pharmacol. 1990;  40 1157-1161
• 10 Metafora S, Porta R, Ravagnan G et al.. Inhibitory effect of SV-IV, a major protein secreted from the rat seminal vesicle epithelium, on phagocytosis and chemotaxis of human polymorphonuclear leukocytes.  J Leukoc Biol. 1989;  46 409-416
• 11 Galdiero F, Tufano M A, De Martino L et al.. Inhibition of macrophage phagocytic activity by SV-IV, a major protein secreted from the rat seminal vesicle epithelium.  J Reprod Immunol. 1989;  16 269-284
• 12 Kelly R W, Critchley H O. Immunomodulation by human seminal plasma: a benefit for spermatozoon and pathogen?.  Hum Reprod. 1997;  12 2200-2207
• 13 Romano-Carratelli C, Galdiero M, Nuzzo I et al.. In vivo inhibition of cell-mediated and humoral immune responses to cellular antigens by SV-IV, a major protein secreted from the rat seminal vesicle epithelium.  J Reprod Immunol. 1995;  28 15-30
• 14 Peluso G, Porta R, Esposito C et al.. Suppression of rat epididymal sperm immunogenicity by a seminal vesicle secretory protein and transglutaminase both in vivo and in vitro.  Biol Reprod. 1994;  50 593-602
• 15 Saez F, Motta C, Boucher D, Grizard G. Antioxidant capacity of prostasomes in human semen.  Mol Hum Reprod. 1998;  4 667-672
• 16 Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells.  Reprod Biol Endocrinol. 2004;  2 12-18
• 17 Metafora V, Franco P, Massa O et al.. Phosphorylation of seminal vesicle protein IV on Ser58 enhances its peroxidase-stimulating activity.  Eur J Biochem. 2001;  268 3858-3869
• 18 Di Micco B, Colonna G, Porta R, Metafora S. Rat protein SV-IV (seminal vesicle protein No. 4) accelerates human blood coagulation in vitro by selective inhibition of antithrombin III.  Biochem Pharmacol. 1994;  48 345-352
• 19 Di Micco B, Stiuso P, Colonna G et al.. A peptide derivative (1-70 fragment) of protein SV-IV accelerates human blood coagulation in vitro by selective inhibition of the heparin-induced antithrombin III activation process.  J Pept Res. 1997;  49 174-182
• 20 Di Micco B, Caen J, Colonna G et al.. Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood.  Eur J Pharmacol. 2000;  391 1-9
• 21 Folk J E, Finlayson J S. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.  Adv Protein Chem. 1977;  31 1-133
• 22 Lorand L, Graham R M. Transglutaminases: crosslinking enzymes with pleiotropic functions.  Nat Rev Mol Cell Biol. 2003;  4 140-156
• 23 Esposito C, Pucci P, Amoresano A, Marino G, Cozzolino A, Porta R. Transglutaminase from rat coagulating gland secretion. Post-translational modifications and activation by phosphatidic acids.  J Biol Chem. 1996;  271 27416-27423
• 24 Williams-Ashman H G. Transglutaminases and the clotting of mammalian seminal fluids.  Mol Cell Biochem. 1984;  58 51-61
• 25 Fawell S E, Higgins S J. Formation of rat copulatory plug: purified seminal vesicle secretory proteins serve as transglutaminase substrates.  Mol Cell Endocrinol. 1987;  53 149-152
• 26 Porta R, Esposito C, Gentile V et al.. Transglutaminase-catalyzed modifications of SV-IV, a major protein secreted from the rat seminal vesicle epithelium.  Int J Pept Protein Res. 1990;  35 117-122
• 27 Porta R, Esposito C, Metafora S et al.. Mass spectrometric identification of the amino donor and acceptor sites in a transglutaminase protein substrate secreted from rat seminal vesicles.  Biochemistry. 1991;  30 3114-3120
• 28 Porta R, Esposito C, De Santis A, Fusco A, Iannone M, Metafora S. Sperm maturation in human semen: role of transglutaminase-mediated reactions.  Biol Reprod. 1986;  35 965-970
• 29 Esposito C, Caputo I. Mammalian transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance.  FEBS J. 2005;  272 615-631
• 30 Romano-Carratelli C, Bentivoglio C, Nuzzo I et al.. Effect of protein SV-IV on experimental salmonella enterica serovar typhimurium infection in mice.  Clin Diagn Lab Immunol. 2002;  9 115-125
• 31 Tufano M A, Porta R, Farzati B et al.. Rat seminal vesicle protein SV-IV and its transglutaminase-synthesized polyaminated derivative SPD2-SV-IV induce cytokine release from human resting lymphocytes and monocytes in vitro.  Cell Immunol. 1996;  168 148-157
• 32 Porta R, Metafora S, Esposito C et al.. Biological activities of a major protein secreted from the rat seminal vesicles after structural modification catalyzed by transglutaminase in vitro.  Immunopharmacology. 1993;  25 179-188
• 33 Ialenti A, Santagada V, Caliendo G et al.. Synthesis of novel anti-inflammatory peptides derived from the amino-acid sequence of the bioactive protein SV-IV.  Eur J Biochem. 2001;  268 3399-3406
• 34 Porta R, Esposito C, Schinina Á et al.. Biological activities of CNBr. fragments of a major protein secreted from the rat seminal vesicle epithelium.  Int J Pept Protein Res. 1994;  44 507-512
• 35 Lwaleed B A, Greenfield R, Stewart A, Birch B R, Cooper A J. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system.  Thromb Haemost. 2004;  92 752-766